Managing Post-operative Pain in Children With Cerebral Palsy Using a Pain Pump

Overview

The purpose of this study is to determine which pain management strategy continuous analgesic pump or orally-should be used in the management of children with cerebral palsy.

Full Title of Study: “Comparing the Effectiveness of an Anesthetic Continuous-infusion Device to Oral Analgesia in Orthopedic Postoperative Pain Control of Children With Cerebral Palsy”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: April 2008

Detailed Description

A prospective randomized controlled trial will be performed on up to 150 subjects who will undergo a tendoachilles lengthening, Strayer's procedure, epiphysiodesis of the femur or femoral osteotomy metal work removal. Subjects will be randomized into two groups: the first group will have an anesthetic pain pump device supplemented with oral analgesia and the second group will only receive oral analgesia. The anesthetic continuous device will be used continuously for 48 hours and with a flow rate of 2ml/hour of 0.25% bupivacaine diluted in accordance to patient weight. Subjects in both groups will receive oral analgesia according to their pain requirements. The amount of oral analgesia used will be documented over 12-hour intervals in a patient diary over a 4 day period. Subjects will have their pain score assessed daily with the use of the Non-Communicating Children's Pain Checklist-Postoperative Version. Their overall satisfaction with post-operative pain management will be assessed at the end of the study with the use of the Parent Total Quality Pain Management questionnaire.

Interventions

  • Drug: oral analgesic
    • per clinical standard of care
  • Drug: intravenous analgesic per pump
    • per clinical standard of care

Arms, Groups and Cohorts

  • Active Comparator: Oral Analgesic Only
    • Group 1 will receive oral analgesic only
  • Active Comparator: anesthetic continuous-infusion + oral analgesia
    • Group 2: anesthetic continuous-infusion device, e.g. intravenous analgesic per pump, with supplemental oral analgesia

Clinical Trial Outcome Measures

Primary Measures

  • The Amount of Oral Analgesic Each Subject Consumed Over the 4-day Study Period.
    • Time Frame: 4 days
    • Results of Mean and total Medication administered between the 2 groups over a 4 day period (Mean Medication Administered in mg/kg; SD)
  • The Amount of Pain Analyzed From Pain Scores for Each of the 4 Days.
    • Time Frame: 4 days
    • Pain scores were assessed using a Visual Analog Scale. Possible scores range from 0 (no pain) to 10 (Worst possible pain).

Secondary Measures

  • Parent and Patient Satisfaction With the Post Operative Pain Management.
    • Time Frame: 4 days
    • Parent responses to questions about pain management traditional paper-based Q method (TPQM) questionnaire.

Participating in This Clinical Trial

Inclusion Criteria

  • Children with cerebral palsy between 3 and 17 years old. – American Society of Anesthesiologists (ASA) intubation grade I, II or III. – Ability of subject or primary caregivers to give informed consent, to understand what the study entails and to be able to complete the patient Pain Diary during the post-operative period. Subjects should be available for daily telephone follow-up until the data is completed and they should be able to return the completed Pain Diary to the Primary Investigator. – Willingness and understanding of parent or guardian to have their child randomized to receive either the continuous infusion pain pump device or oral analgesics for their child's pain management. – English or Spanish-speaking care parent or guardians who are able to complete the Pain Diary. Exclusion Criteria:

  • ASA IV or V, – Known allergy or sensitivity to bupivacaine, – Subjects who will have more than the above mentioned procedure performed during their surgical visit, – Subjects with significant kidney or liver disease, – Parents/guardians who are assessed by the PI or co-investigators to be unable or unwilling to complete the study's Pain Diary or behavioral tools, and – Parents/guardians who are unwilling to allow their child to be randomly assigned to receive either the pain pump with oral analgesics or oral medications alone.

Gender Eligibility: All

Minimum Age: 3 Years

Maximum Age: 17 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • University of Colorado, Denver
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Frank Chang, MD, Principal Investigator, Children’s Hospital Colorado

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.